Healthcare Sector Analytics

Market size, company revenue, drug approvals, clinical trials, regulation, hospitals, doctors, drug spending, labs and devices

Brand drugFirst approved 2012

Evekeo(Amphetamine Sulfate)

Medicare prescription drug cost, prescriptions and prescribers, 2024

$74K

Medicare cost, 2024

Medicare drug plans spent $73,786 on Evekeo (amphetamine sulfate) in 2024, for 80 prescriptions and refills filled by 22 patients. Spending fell 33% from 2023 to 2024.

Medicare cost, 2024

$74K

-33.4% from 2023

Prescriptions

80

$922.32 per claim

Patients

22

25 prescribers

Total spending, 2024

$74K

$3,353.90 per patient

Questions and answers

How much does Medicare spend on Evekeo?

Medicare prescription drug plans paid $74K for Evekeo in 2024, for 80 prescriptions and refills to 22 patients (down 33.4% from 2023). The average cost per claim was $922.32.

Which state spends the most on Evekeo?

New York had the highest Medicare cost for Evekeo in 2024: $17K for 14 claims, followed by Pennsylvania ($10K).

Who prescribes Evekeo the most?

Patricia A Leone, family practice in New York, NY, had the highest Medicare cost for Evekeo in 2024: 12 claims costing $16K.

Spending over the years

Medicare spending by year

All plans and makers

Prescriber data: cost by year

Medicare spending on Evekeo was $74K in 2024, after a high of $120K in 2020.

By state

Where the prescribers practice, 2024

Medicare cost by state

States with the highest cost

Top prescribers of Evekeo, 2024

By Medicare drug cost

PrescriberTypeClaimsPatientsCost
Patricia A Leone New York, NYFamily Practice12Under 11$16K

Prescriber data by year

YearPrescribersClaimsPatientsCost
2022319924$66K
20232611125$111K
2024258022$74K

Makers, 2024

Spending by manufacturer as listed in the spending data

ManufacturerClaimsSpending
Arbor/Azurity80$74K

Medicaid spending by quarter

Amount reimbursed by state Medicaid programs, all states

Amount reimbursed

Codes

National drug codes (packages)
2
RxNorm concept IDs
1600695, 1600698, 1600700, 884655
Application numbers
ANDA200166

More drugs: Medicare drug spending and the Prescriptions view.

Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.

LinkedInLinkedInXXYouTubeYouTube